CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201712/31/201612/31/201512/31/2014
Net Income2,940,0001,999,0001,602,0001,999,900
Operating Activities, Cash Flows Provided By or Used In
Depreciation471,000505,000402,000369,400
Adjustments To Net Income-336,000926,000537,000339,900
Changes In Accounts Receivables-236,000-222,000-305,000-166,300
Changes In Liabilities293,000626,000564,000242,500
Changes In Inventories-42,000-55,000-51,000-56,500
Changes In Other Operating Activities-73,00085,000-326,00038,300
Total Cash Flow From Operating Activities5,246,0004,165,0002,785,0002,806,300
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-279,000-236,000-286,000-150,300
Investments-2,585,000-765,0001,730,000-552,900
Other Cash flows from Investing Activities-27,000-1,000-8,000-24,800
Total Cash Flows From Investing Activities-2,891,000-1,002,000-6,259,000-1,438,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings1,564,0001,564,0007,297,0002,025,300
Other Cash Flows from Financing Activities--33,000-9,000235,200
Total Cash Flows From Financing Activities-1,584,000-1,834,0004,283,000-417,400
Effect Of Exchange Rate Changes72,000-39,000-51,000-63,700
Change In Cash and Cash Equivalents843,0001,290,000758,000887,200